🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-09
Trial ID
NCT00005787
The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (C...
Status
Completed
Location
Dept of Rheumatology, Sahlgrenska University Hospital
Start Date
2009-06
Trial ID
NCT01470638
RATIONALE: Drugs such as flt3L may stimulate a person's immune system and h...
Status
Completed
Location
Veterans Affairs Medical Center - Birmingham
Start Date
2000-07
Trial ID
NCT00006223
Treatments Being Tested
The purpose of this study is to test a new way of treating the most common ...
Status
Terminated
Location
Albert Einstein College of Medicine
Start Date
2021-01-01
Trial ID
NCT04491084
Treatments Being Tested
This research study is being done to find out if the immunotherapy drugs ca...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2022-04-20
Trial ID
NCT05029999
Treatments Being Tested
This is a study to determine the maximum tolerated dose (MTD) for CDX-1140 ...
Status
Completed
Location
HonorHealth Research Insititute
Start Date
2017-12-01
Trial ID
NCT03329950
Treatments Being Tested
The investigators have recently demonstrated the strong impact in terms of ...
Status
Completed
Location
Strasbourg University Hospital
Start Date
2021-06-08
Trial ID
NCT04641910
Treatments Being Tested
Based on promising data from our laboratory demonstrating synergy between a...
Status
Completed
Location
Montefiore Medical Center
Start Date
2016-07
Trial ID
NCT02839265
Treatments Being Tested
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248
RATIONALE: Biological therapies such as flt3L and CD40-ligand use different...
Status
Completed
Location
Surgery Branch
Start Date
2001-03
Trial ID
NCT00020540
Treatments Being Tested